The countrywide vaccination drive was rolled out on January 16, 2021, with the healthcare workers getting inoculated in the first phase. Vaccination of the frontline workers started from February 2 last year.
The government then decided to expand its vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from May 1 last year.
The Centre said it is relevant that there is a logical rationale in not disclosing raw data either segregated or otherwise and the citizens have a reason to rely upon the statutory system in place, the wisdom of domain experts consisting of statutory committees and the decision-making process while going for vaccination.
Corbevax is India's third indigenous Covid-19 vaccine after Covaxin and Zydus Cadila's ZyCoV-D vaccine.
The next phase of COVID-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions. The country launched vaccination for all people aged more than 45 years from April 1.
With the administration of over 21 lakh Covid vaccine doses in the last 24 hours, India's Covid inoculation coverage has reached 178 crore as of Thursday morning, the ministry said. This has been achieved through 2,05,41,983 sessions.
The Centre on Wednesday informed the Supreme Court that 96.8 percent of India's adult population have been administered with first dose of the Covid vaccine and 81.3 percent have been administered the second dose.
The Corbevax vaccine is administered through intramuscular route with two doses, scheduled 28 days apart, and is stored at 2 to 8 degrees Celsius temperature and presented as 0.5 ml (single dose) and 5 ml (10 doses) vial and 10 mL (20 doses) vial pack.
The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults on December 28.
The suggestion letter reads further that the prioritization concept adopted by the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) lacked representation of health professionals with disabilities, and organizations of doctors with disabilities were never involved in the development of vaccine priority groups by either NEGVAC or the Indian Council of Medical Research (ICMR).
Around 99 percent of the eligible adult population have received at least one dose of Covid-19 vaccine in Odisha, the Director of Health and Family Welfare, Bijay Panigrahi, informed on Saturday.
Do COVID19 Vaccines Need An Upgrade?
New York City has around 3,70,000 municipal workers with the vast majority of them having been vaccinated.
With the administration of more than 49.16 lakh vaccine doses in the last 24 hours, India's Covid-19 vaccination coverage has exceeded 172.81 crore as per the health ministry report on Sunday morning.
India's first homegrown Messenger RNA (mRNA) Covid19 vaccine, being developed by Pune-based Gennova Biopharmaceuticals, is currently under final clinical trials, NITI Aayog's Member, Health, Dr V.K. Paul, said on Thursday.